Overview

Exploratory Lapatinib (Positron Emission Tomography) PET Study in Subjects With Breast Cancer

Status:
Completed
Trial end date:
2013-03-18
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out how much lapatinib can enter both normal brains and brains in which tumours secondary to breast cancer have developed.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Lapatinib